cas 3680-69-1|| where to buy 4-chloro-7H-pyrrolo[2,3-d]pyrimidine

Nom du produit:4-chloro-7H-pyrrolo[2,3-d]pyrimidine

IUPAC Name:4-chloro-7H-pyrrolo[2,3-d]pyrimidine

Unité d'emballage	Stock disponible	Prix($)
CM101908-100g	in stock	ħŁ
CM101908-500g	in stock	ǎŁţ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:3680-69-1; Formule moléculaire:C6H4ClN3; Point de fusion:-; Code SMILES:ClC1=C2C=CNC2=NC=N1; Densité:

: Numéro de catalogue:CM101908; Poids moléculaire:153.57; Point d'ébullition:325.9°C at 760 mmHg; N° Mdl:MFCD01686865; Stockage:Keep in a dry and a tight container and store at ambient temperature

: Pyrrolopyrimidines; Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.

: Delgocitinib; Positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE). Delgocitinib cream demonstrated a superior reduction in Hand Eczema Severity Index score from baseline to Week 12 compared to alitretinoin capsules as its primary outcome measure.
Delgocitinib cream is an investigational, first-in-class, topical pan-Janus kinase (JAK) inhibitor for CHE. It inhibits the activation of JAK-STAT signaling, which plays a key role in the pathogenesis of CHE.